Renaissance Technologies’s Vir Biotechnology VIR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.37M | Sell |
1,064,500
-55,900
| -5% | -$282K | 0.01% | 1478 |
|
|
2025
Q1 | $7.26M | Sell |
1,120,400
-117,200
| -9% | -$759K | 0.01% | 1194 |
|
|
2024
Q4 | $9.08M | Buy |
1,237,600
+55,300
| +5% | +$406K | 0.01% | 1077 |
|
|
2024
Q3 | $8.86M | Sell |
1,182,300
-147,400
| -11% | -$1.1M | 0.01% | 1103 |
|
|
2024
Q2 | $11.8M | Sell |
1,329,700
-26,400
| -2% | -$235K | 0.02% | 828 |
|
|
2024
Q1 | $13.7M | Buy |
1,356,100
+61,500
| +5% | +$623K | 0.02% | 827 |
|
|
2023
Q4 | $13M | Sell |
1,294,600
-59,800
| -4% | -$602K | 0.02% | 817 |
|
|
2023
Q3 | $12.7M | Buy |
1,354,400
+186,300
| +16% | +$1.75M | 0.02% | 785 |
|
|
2023
Q2 | $28.7M | Buy |
1,168,100
+7,600
| +0.7% | +$186K | 0.04% | 509 |
|
|
2023
Q1 | $27M | Buy |
1,160,500
+102,100
| +10% | +$2.38M | 0.04% | 576 |
|
|
2022
Q4 | $26.8M | Sell |
1,058,400
-454,094
| -30% | -$11.5M | 0.04% | 582 |
|
|
2022
Q3 | $29.2M | Buy |
1,512,494
+950,094
| +169% | +$18.3M | 0.04% | 500 |
|
|
2022
Q2 | $14.3M | Buy |
562,400
+468,000
| +496% | +$11.9M | 0.02% | 911 |
|
|
2022
Q1 | $2.43M | Buy |
94,400
+36,500
| +63% | +$939K | ﹤0.01% | 2083 |
|
|
2021
Q4 | $2.42M | Buy |
+57,900
| New | +$2.42M | ﹤0.01% | 1985 |
|
|
2021
Q3 | – | Sell |
-80,102
| Closed | -$3.79M | – | 3869 |
|
|
2021
Q2 | $3.79M | Buy |
+80,102
| New | +$3.79M | ﹤0.01% | 1806 |
|
|
2020
Q2 | – | Sell |
-58,500
| Closed | -$2.01M | – | 3793 |
|
|
2020
Q1 | $2.01M | Buy |
+58,500
| New | +$2.01M | ﹤0.01% | 2046 |
|